CNXU
Conexeu Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.96
−6.42%1
Insider buys (3m)
0
Insider sells (3m)
$162.0K
Net value (3m)
-58.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 15, 2026 | Sharpe Jeffrey Nathan · director | M-Exempt | 500,000 | $0.00 |
| Jun 23, 2026 | Purcell Lynn Sebastian · director, 10 percent owner: | Purchase | 202,500 | $0.80 |
| Jun 23, 2026 | Purcell Lynn Sebastian · director, 10 percent owner: | M-Exempt | 202,500 | $0.80 |
| Jun 22, 2026 | Wright Michael G. · 10 percent owner | M-Exempt | 250,000 | $0.00 |
| May 28, 2026 | Wright Michael G. · 10 percent owner | M-Exempt | 400,000 | $0.00 |
| May 26, 2026 | Sharpe Jeffrey Nathan · director | M-Exempt | 500,000 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 15, 2026